A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

Clinical trial NCT03743246 · TERMINATED

Trial details

NCT number: NCT03743246
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, Non-Hodgkin

Start date: 2018-10-17
Primary completion: 2024-01-26
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.